2) Miyamoto S, Duncan GE, Marx CE, Lieberman JA, Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs, Mol Psychiatry, 2005, 10, 79-104.
3) Gorwood P, Meeting everyday challenges: antipsychotic therapy in the real world, Eur Neuropsychopharmacol, 2006, 16 (suppl 3), S156-S162.
4) Keller WR, Fischer BA, McMahon R, Meyer W, Blake M, Buchanan RW, Community Adherence to Schizophrenia Treatment and Safety Monitoring Guidelines, J Nerv Ment Dis, 2014, 202, 6-12.
5) Ozbilen M, Adams CE, Systematic Overview of Cochrane Reviews for Anticholinergic Effects of Antipsychotic Drugs, J Clin Psychopharmacol, 2009, 29, 141-146.